AQR Capital Management
SRTA

AQR Capital Management’s Strata Critical Medical Inc SRTA Stock Holding History

AQR Capital Management’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$552K Sell
132,141
-7,067
-5% -$34K ﹤0.01% 3077
2025
Q4 		$670K Sell
139,208
-10,846
-7% -$52.5K ﹤0.01% 2768
2025
Q3 		$759K Sell
150,054
-11,537
-7% -$51K ﹤0.01% 2590
2025
Q2 		$651K Sell
161,591
-45,456
-22% -$148K ﹤0.01% 2466
2025
Q1 		$565K Sell
207,047
-40,640
-16% -$146K ﹤0.01% 2357
2024
Q4 		$1.05M Sell
247,687
-257,722
-51% -$981K ﹤0.01% 1866
2024
Q3 		$1.49M Sell
505,409
-41,221
-8% -$131K ﹤0.01% 1643
2024
Q2 		$1.9M Buy
546,630
+162,867
+42% +$543K ﹤0.01% 1467
2024
Q1 		$1.09M Buy
383,763
+228,837
+148% +$706K ﹤0.01% 1648
2023
Q4 		$547K Buy
+154,926
New +$445K ﹤0.01% 1845
2023
Q2 		– Sell
-62,085
Closed -$210K – 2194
2023
Q1 		$210K Buy
62,085
+24,309
+64% +$99.1K ﹤0.01% 2042
2022
Q4 		$135K Buy
+37,776
New +$161K ﹤0.01% 2116

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management's SRTA Position: Q1 2026 in Review

AQR Capital Management reduced its Strata Critical Medical Inc (SRTA) stake by 5.1% in Q1 2026, selling an estimated $34K and leaving 132,141 shares worth $552K. The position accounts for ﹤0.01% of the portfolio, ranked #3077.

AQR Capital Management first reported a position in SRTA in Q4 2022 and has held it in 12 quarters since. The position peaked at $1.9M in Q2 2024. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • AQR Capital Management held 132,141 shares of Strata Critical Medical Inc worth $552K as of Q1 2026.
  • AQR Capital Management sold 7,067 Strata Critical Medical Inc shares in Q1 2026, an estimated $34K.
  • Strata Critical Medical Inc made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3077 holding.
  • AQR Capital Management first reported a position in Strata Critical Medical Inc in Q4 2022 and has held it in 12 quarters since.
  • AQR Capital Management's Strata Critical Medical Inc position peaked at $1.9M in Q2 2024.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.